Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,503,566 | $1,811,235 | $1,330,696 | $3,220,530 |
| - Cash | $288,455 | $293,807 | $288,027 | $233,097 |
| + Debt | $471,839 | $321,014 | $229,364 | $200,983 |
| Enterprise Value | $1,686,950 | $1,838,442 | $1,272,033 | $3,188,416 |
| Revenue | $2,034,540 | $1,386,661 | $1,144,163 | $773,915 |
| % Growth | 46.7% | 21.2% | 47.8% | – |
| Gross Profit | $271,388 | $214,958 | $199,478 | $177,773 |
| % Margin | 13.3% | 15.5% | 17.4% | 23% |
| EBITDA | $141,842 | $123,688 | $112,079 | $100,659 |
| % Margin | 7% | 8.9% | 9.8% | 13% |
| Net Income | $43,149 | $60,717 | $45,171 | $68,923 |
| % Margin | 2.1% | 4.4% | 3.9% | 8.9% |
| EPS Diluted | 0.9 | 1.29 | 0.99 | 1.52 |
| % Growth | -30.2% | 30.3% | -34.9% | – |
| Operating Cash Flow | $52,198 | $68,227 | $82,128 | $70,335 |
| Capital Expenditures | -$8,031 | -$28,529 | -$22,940 | -$19,223 |
| Free Cash Flow | $44,167 | $39,698 | $59,188 | $51,112 |